Literature DB >> 13972347

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA.

C C PORTER, L S WATSON, D C TITUS, J A TOTARO, S S BYER.   

Abstract

Entities:  

Keywords:  DOPA DECARBOXYLASE; HYDRAZINES

Mesh：

Substances：

Year:  1962        PMID： 13972347     DOI： 10.1016/0006-2952(62)90166-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  27 in total

1.  Analgesic effects of 3-carboxysalsolinol alone and in combination with morphine.

Authors:  A Marshall; M Hirst; K Blum
Journal:  Experientia       Date:  1977-06-15

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Effects of chlorimipramine and protriptyline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice.

Authors:  K Modigh
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Mode of action of L-DOPA on central noradrenaline mechanisms.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 6.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

7.  The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats.

Authors:  P S Leppert; M Cortese; J A Fix
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

8.  Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.

Authors:  Y Furuta; K Hashimoto; K Iwatsuki; O Takeuchi
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

9.  Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.

Authors:  D B Calne; J L Reid; S D Vakil; S Rao; A Petrie; C A Pallis; J Gawler; P K Thomas; A Hilson
Journal:  Br Med J       Date:  1971-09-25

10.  Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.

Authors:  P T Männistö; P Tuomainen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.